Epilepsy in autism spectrum disorders

Epilepsia

Volumn 51, Issue SUPPL. 5, 2010, Pages 78-

  Stafstrom, Carl E ^a   Hagerman, Paul J ^b   Pessah, Isaac N ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fragile X syndrome; Idiopathic ASD; Metabotropic glutamate receptor; mTOR; Seizures; Tuberous sclerosis complex

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ARTICLE; AUTISM; CLINICAL FEATURE; EPILEPSY; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; NEUROTRANSMISSION; PHENOTYPE; PRIORITY JOURNAL;

EID: 78650354437     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2010.02864.x     Document Type: Article

References (4)

1. Berry-Kravis E,. (2002) Epilepsy in fragile X syndrome. Dev Med Child Neurol 44: 724-728.
2. Hagerman PJ, Stafstrom CE,. (2009) Origins of epilepsy in fragile X syndrome. Epilepsy Curr 9: 108-112.
3. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ,. (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci 28: 5422-5432.
4. Tuchman R, Moshé SL, Rapin I,. (2009) Convulsing toward the pathophysiology of autism. Brain Dev 31: 95-103.